Clinical trial
A Multi-Centre, Open-Label Study Assessing the Efficacy and Tolerability of Lanthanum Carbonate in the Reduction of Serum Phosphate Levels in End Stage Renal Disease Patients Receiving Dialysis
NCT00151931 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Centre, Open-Label Study Assessing the Efficacy and Tolerability of Lanthanum Carbonate in the Reduction of Serum Phosphate Levels in End Stage Renal Disease Patients Receiving Dialysis
- Lead sponsor
- Shire
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 11, 2004
- Completion date
- January 12, 2006
- Enrollment
- 456
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.